Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.92 Insider Own2.70% Shs Outstand34.77M Perf Week-5.13%
Market Cap411.33M Forward P/E- EPS next Y-1.27 Insider Trans-0.15% Shs Float34.04M Perf Month-5.13%
Income-169.30M PEG- EPS next Q-0.26 Inst Own- Short Float25.33% Perf Quarter-29.71%
Sales474.00M P/S0.87 EPS this Y22.80% Inst Trans0.33% Short Ratio12.44 Perf Half Y-50.04%
Book/sh21.61 P/B0.55 EPS next Y40.70% ROA-4.30% Target Price15.50 Perf Year-43.12%
Cash/sh11.34 P/C1.04 EPS next 5Y- ROE-8.80% 52W Range10.70 - 26.10 Perf YTD-22.12%
Dividend- P/FCF7.06 EPS past 5Y-61.90% ROI-11.90% 52W High-54.67% Beta0.41
Dividend %- Quick Ratio3.00 Sales past 5Y42.40% Gross Margin54.50% 52W Low10.56% ATR0.46
Employees467 Current Ratio3.20 Sales Q/Q-31.40% Oper. Margin-17.50% RSI (14)31.51 Volatility4.21% 3.59%
OptionableYes Debt/Eq0.38 EPS Q/Q-23.80% Profit Margin-13.90% Rel Volume1.18 Prev Close11.91
ShortableYes LT Debt/Eq0.35 EarningsMay 09 BMO Payout- Avg Volume693.24K Price11.83
Recom3.10 SMA20-6.30% SMA50-13.93% SMA200-36.20% Volume818,340 Change-0.67%
Mar-20-19Initiated SunTrust Hold
Dec-14-18Reiterated B. Riley FBR Buy $29 → $20.50
Nov-06-18Downgrade JP Morgan Neutral → Underweight
Jun-15-18Downgrade Janney Buy → Neutral
May-21-18Resumed Leerink Partners Mkt Perform
Mar-14-18Reiterated B. Riley FBR, Inc. Neutral $16 → $23
Feb-15-18Upgrade Janney Neutral → Buy
Dec-07-17Initiated B. Riley FBR, Inc. Neutral $16
Oct-23-17Initiated Piper Jaffray Neutral $18
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
Nov-19-15Reiterated Deutsche Bank Hold $50 → $43
Sep-03-15Resumed Deutsche Bank Hold $75 → $71
Sep-01-15Initiated Raymond James Outperform $75
Apr-16-19 08:00AM  AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations GlobeNewswire
Apr-12-19 09:01AM  The AMAG Pharmaceuticals (NASDAQ:AMAG) Share Price Is Down 51% So Some Shareholders Are Wishing They Sold Simply Wall St.
08:00AM  AMAG Pharmaceuticals Appoints New Members to Board of Directors GlobeNewswire
Apr-02-19 08:00AM  AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference GlobeNewswire
Mar-20-19 08:00AM  March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program GlobeNewswire
Mar-18-19 12:43PM  New Doubt on Treatment to Prevent Preterm Birth The Wall Street Journal
Mar-13-19 10:46AM  Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News Zacks
Mar-11-19 10:35AM  AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study Zacks +12.93%
Mar-09-19 09:31AM  Why Is AMAG Pharmaceuticals (AMAG) Down 24.5% Since Last Earnings Report? Zacks
Mar-08-19 11:26AM  Amag's shares fall after $323M pregnancy drug fails in post-approval trial American City Business Journals -17.71%
09:00AM  AMAG Pharmaceuticals stock down 6% after latest trial of Makena fails to meet primary endpoints MarketWatch
08:00AM  AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena® (hydroxyprogesterone caproate injection) GlobeNewswire
Mar-07-19 08:00AM  AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting GlobeNewswire
Mar-05-19 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Mar-01-19 03:48PM  AMAG Pharmaceuticals Inc (AMAG) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-28-19 12:31PM  Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-19-19 08:00AM  AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference GlobeNewswire
Feb-09-19 03:10PM  Edited Transcript of AMAG earnings conference call or presentation 7-Feb-19 1:00pm GMT Thomson Reuters StreetEvents
Feb-08-19 08:59PM  AMAG Pharmaceuticals (AMAG) Q4 2018 Earnings Conference Call Transcript Motley Fool
10:00AM  AMAG Q4 Loss Narrower Than Expected, Revenues Lag Estimates Zacks
Feb-07-19 08:55AM  AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Misses Revenue Estimates Zacks -7.60%
07:57AM  AMAG Pharmaceuticals: 4Q Earnings Snapshot Associated Press
07:00AM  AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update GlobeNewswire
Jan-30-19 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET GlobeNewswire
Jan-17-19 08:00AM  AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals GlobeNewswire
07:30AM  Research Report Identifies Edison International, MPLX LP, Moody's, AMAG Pharmaceuticals, Cross Country Healthcare, and New Mountain Finance with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-15-19 08:00AM  AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs GlobeNewswire
Jan-07-19 07:00AM  AMAG Pharmaceuticals Announces Preliminary 2018 Financial Results and Provides 2019 Financial Guidance GlobeNewswire
Dec-27-18 08:25AM  AMAG Up Nearly 10% in a Year on Label Expansion, Acquisitions Zacks
Dec-19-18 08:00AM  AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-14-18 10:25AM  AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals Zacks
Dec-13-18 06:30AM  AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals GlobeNewswire
Dec-04-18 12:06PM  Estimating The Fair Value Of AMAG Pharmaceuticals Inc (NASDAQ:AMAG) Simply Wall St. -5.11%
Dec-03-18 08:00AM  Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia Patients GlobeNewswire
Nov-29-18 12:50PM  Paul Tudor Jones Continues to Buy Apple, Alibaba GuruFocus.com
08:00AM  AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia GlobeNewswire
Nov-26-18 05:37PM  AMAG's Label Expansion of Lead Products Raises Share Price Zacks
Nov-08-18 08:10AM  Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-07-18 05:31PM  Edited Transcript of AMAG earnings conference call or presentation 1-Nov-18 12:00pm GMT Thomson Reuters StreetEvents +6.20%
Nov-06-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Nov-02-18 06:11PM  AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues Zacks
Nov-01-18 05:08PM  Here's Why AMAG Pharmaceuticals Tumbled 12.7% Today Motley Fool -12.74%
12:12PM  AMAG Pharmaceuticals Inc (AMAG) Q3 2018 Earnings Conference Call Transcript Motley Fool
12:10PM  AMAG Pharmaceuticals (AMAG) Reports Q3 Loss, Tops Revenue Estimates Zacks
10:42AM  AMAG Pharmaceuticals: 3Q Earnings Snapshot Associated Press
07:00AM  AMAG Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-29-18 09:02AM  The Zacks Analyst Blog Highlights: Allergan, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and AMAG Pharmaceuticals Zacks
Oct-26-18 04:02PM  5 Drug/Biotech Stocks Likely to Beat Estimates in Q3 Earnings Zacks
Oct-25-18 10:33AM  AMAG Pharmaceuticals (AMAG) Q3 Earnings Preview: What to Watch Ahead of the Release Zacks
08:00AM  AMAG Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, November 1, 2018 at 8:00 a.m. ET GlobeNewswire
Oct-17-18 08:15AM  Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-09-18 08:51AM  Is the Options Market Predicting a Spike in AMAG Pharmaceuticals (AMAG) Stock? Zacks
Oct-05-18 08:07AM  New Strong Sell Stocks for October 5th Zacks
Oct-04-18 08:00AM  AMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone GlobeNewswire
Sep-27-18 11:37AM  AMAG In-Licenses Global Rights to Orphan Drug Candidate Zacks -5.62%
Sep-26-18 06:30AM  AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia GlobeNewswire
Sep-20-18 09:15AM  AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause GlobeNewswire
Sep-13-18 07:30AM  Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
Sep-06-18 08:00AM  AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes GlobeNewswire
Sep-04-18 10:19AM  Options Traders Expect Huge Moves in AMAG Pharmaceuticals (AMAG) Stock Zacks
Aug-23-18 03:16PM  Edited Transcript of AMAG earnings conference call or presentation 2-Aug-18 12:00pm GMT Thomson Reuters StreetEvents
08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
07:40AM  Factors of Influence in 2018, Key Indicators and Opportunity within AMAG Pharmaceuticals, Pier 1 Imports, Gogo, IDT, Axalta Coating, and Sprouts Farmers Market New Research Emphasizes Economic Growth GlobeNewswire
Aug-10-18 06:19AM  Note to Musk: Tesla isn't the only company targeted by short sellers. Here's who tops the list in Mass. American City Business Journals
Aug-06-18 04:45PM  California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform PR Newswire
04:30PM  AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry® GlobeNewswire
07:30AM  AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs GlobeNewswire
Aug-02-18 12:10PM  AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Misses Revenue Estimates Zacks
11:04AM  AMAG Pharmaceuticals: 2Q Earnings Snapshot Associated Press
07:00AM  AMAG Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
06:00AM  AMAG Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-18 08:00AM  AMAG Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2, 2018 at 8:00 a.m. ET GlobeNewswire
Jul-17-18 07:05PM  GI Chill Acquisition LLC -- Moody's assigns a B3 CFR to GI Chill Acquisition LLC; stable outlook Moody's
Jun-18-18 08:30AM  Analysis: Positioning to Benefit within The Stars Group, AMAG Pharmaceuticals, ResMed, WestRock, Briggs & Stratton, and II-VI Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-15-18 08:33AM  [$$] GI Partners Buys Cord Blood Registry and Sperm and Egg Bank The Wall Street Journal
07:10AM  California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform PR Newswire
07:00AM  AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry® GlobeNewswire
Jun-13-18 07:25AM  Initiating Free Research Reports on ArQule and Three Other Biotech Equities ACCESSWIRE
Jun-11-18 04:44PM  AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies GlobeNewswire
Jun-04-18 07:00AM  AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide GlobeNewswire
May-29-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conference GlobeNewswire
May-09-18 07:00AM  AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopause GlobeNewswire +5.73%
May-08-18 07:30AM  Wired News Auris Medical Reported Publication Related to AM-111 in Peer-Reviewed Scientific Journal Hearing Research ACCESSWIRE +5.31%
May-07-18 05:12AM  Edited Transcript of AMAG earnings conference call or presentation 3-May-18 12:00pm GMT Thomson Reuters StreetEvents
May-04-18 02:17PM  AMAG Pharma (AMAG) Q1 Loss Wider Than Expected, Lifts View Zacks
May-03-18 10:39AM  AMAG Pharmaceuticals: 1Q Earnings Snapshot Associated Press -7.25%
07:00AM  AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance GlobeNewswire
May-02-18 08:00AM  AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer GlobeNewswire
Apr-30-18 12:34PM  Calculating The Fair Value Of AMAG Pharmaceuticals Inc (NASDAQ:AMAG) Simply Wall St.
Apr-27-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Apr-26-18 08:00AM  AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3, 2018 at 8:00 a.m. ET GlobeNewswire
Apr-24-18 03:53AM  Investor Expectations to Drive Momentum within AMN Healthcare Services, Cass Information, William Lyon Homes, AMAG Pharmaceuticals, Intersect ENT, and First Financial Discovering Underlying Factors of Influence GlobeNewswire
Apr-10-18 03:17PM  Edited Transcript of AMAG presentation 8-Mar-17 3:25pm GMT Thomson Reuters StreetEvents
Mar-29-18 09:20AM  AMAG Pharma (AMAG) Down 10.6% Since Earnings Report: Can It Rebound? Zacks +8.63%
Mar-26-18 08:00AM  Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women PR Newswire
08:00AM  AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women GlobeNewswire
Mar-05-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-28-18 09:09AM  AMAG Pharma (AMAG) Beats on Q4 Earnings, Misses on Revenues Zacks
Feb-27-18 08:21PM  Edited Transcript of AMAG earnings conference call or presentation 27-Feb-18 1:00pm GMT Thomson Reuters StreetEvents
11:05AM  AMAG Pharmaceuticals tops Street 4Q forecasts Associated Press
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, anemia management, and cancer supportive care in the United States. It markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company's products candidates include Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women; AMAG-423, a polyclonal antibody in development for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent for the treatment of oral anticoagulants or low molecular weight heparin. It sells Feraheme to authorized wholesalers and specialty distributors. The company has a license agreement with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio LLC, Perosphere Pharmaceuticals Inc., Antares Pharma, Inc., and Abeona Therapeutics, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vittiglio JosephEVP, General CounselMar 07Sale14.011,42519,96478,955Mar 11 04:41 PM
HEIDEN WILLIAM KPresident & CEOAug 07Sale25.005,000125,000328,015Aug 08 05:17 PM
HEIDEN WILLIAM KPresident & CEOJun 04Sale25.0020,000500,000333,015Jun 05 07:21 AM